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Recent demonstration that probiotics administration has positive effects on mood state
in healthy populations suggests its possible role as an adjunctive therapy for depression
in clinical populations and as a non-invasive strategy to prevent depressive mood state
in healthy individuals. The present study extends current knowledge on the beneficial
effects of probiotics on psychological well-being, as measured by changes in mood (e.g.,
cognitive reactivity to sad mood, depression, and anxiety), personality dimensions, and
quality of sleep, which have been considered as related to mood. For this double-blind,
placebo-controlled study 38 healthy volunteers assigned to an experimental or control
group assumed a daily dose of a probiotic mixture (containing Lactobacillus fermentum
LF16, L. rhamnosus LR06, L. plantarum LP01, and Bifidobacterium longum BL04) or
placebo, respectively, for 6 weeks. Mood, personality dimensions, and sleep quality were
assessed four times (before the beginning of the study, at 3 and 6 weeks, and at 3 weeks
of washout). A significant improvement in mood was observed in the experimental group,
with a reduction in depressive mood state, anger, and fatigue, and an improvement in
sleep quality. No between-groups differences were found. These findings corroborate the
positive effect of probiotics onmood state and suggest that probiotics administrationmay
improve psychological well-being by ameliorating aspects of mood and sleep quality.
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INTRODUCTION
Gut and brain communicate with each other via the gut-brain axis, a specific pathway that
involves the neural, endocrine, and immune systems (1–4). The intestinal microbiota plays a crucial
role in this bidirectional communication, since it can influence mood and cognitive functions
by producing neurotransmitter precursors that reach the brain through the endocrine and the
autonomic nervous systems where they regulate the level of specific neurotransmitters (5, 6).
It has been hypothesized that modifying the microbial environment by means of probiotics,
for instance, may help to improve mood and cognitive functions. This hypothesis is supported
by studies using animal models. Li et al. (7) found an improvement in spatial memory and
problem solving in rats after probiotics supplementation. Other studies using rodent models
showed beneficial effects of probiotics on anxiety and depression (8, 9). Research involving human
participants is still scant. Among the existing literature on this topic, some studies showed no effects
of probiotics on mood (10), but other found promising data. For instance, a recent fMRI study
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demonstrated that 4 weeks of probiotic intake reduced the
activity of brain regions involved in emotional processing (11).
Moreover, a recent triple blind, randomized, placebo-controlled
study showed reduced cognitive reactivity to sad mood after
a 4-week intervention with multispecies probiotics (12). Sleep
quality also seems to benefit from probiotic supplementation.
Takada et al. (13) reported an improvement in sleep quality in
academic students during a period of increasing stress after 11
weeks of probiotics consumption. Beneficial effects of probiotics
were also reported in studies involving clinical populations.
For instance, Rao et al. (14) found that anxiety in patients
with chronic fatigue syndrome was reduced after 2 months of
probiotics intake. Overall, these studies suggest that probiotics
administration might be used to improve mood and cognitive
functions (e.g., emotional processing).
The aim of the present explorative study was to extend our
current knowledge about the beneficial effects of probiotics on
psychological well-being by investigating different aspects of
mood (e.g., cognitive reactivity to sad mood, depression, and
anxiety) and various dimensions of personality related to mood,
including optimism, pessimism, and motivational drive. Also, we
investigated the potential effects of probiotics on sleep quality,
which is also known to affect mood (15). In line with previous
findings, we expected an improvement in mood only in the
group that received the probiotics. Additionally, we hypothesized
an improvement in perceived sleep quality and personality
dimensions known to be related to anxiety and depression.
Examining the ways in which probiotics influence mood,
personality traits, and sleep may help to gain a better
understanding of the relationship between the gut and the brain
and to develop new applications for psychological well-being.
MATERIALS AND METHODS
Participants were recruited from students of the University of
Verona (Italy) where the investigation took place and where
data were collected. Computation of the sample size was
performed with G-Power 3.1 (16), considering F-test within-
between interaction with two groups (experimental and control)
and four evaluation sessions (T0, T1, T2, T3) (see the procedure
for details). Assuming a priori medium effect size of 0.25 (17), an
α error probability of 0.05, and a power (1-β error probability)
of 0.90, the resulting total sample size is 30. We recruited more
participants to prevent reduction in statistical power due to
potential drop-outs.
Thirty-eight male and female adults volunteered for the study
(13 women, mean age ± SD, 22.00 ± 3.02, age range, 19–33
years). Inclusion criterion was an age between 18 and 35 years.
Exclusion criteria were: psychiatric or neurological disorders,
celiac disease, lactose intolerance, or allergies or other ongoing
illnesses (i.e., irritable bowel syndrome, diabetes, ulcerative
colitis, etc.) or recent antibiotic treatment (i.e.,<3 months before
the beginning of the study). Participants who smoked more than
10 cigarettes per day were excluded.
Participants were screened via structured interviews by
three experimenters (MF, AM, ES) who collected data on
demographics and physical activity. In order to account for
potential bias due to premenstrual syndrome, the women were
also asked about their monthly physical and emotional changes.
Participants were assigned to receive probiotics or placebo
by means of stratified randomization method. Since the amount
of physical activity can influence cognitive functions, mood and
sleep quality (18, 19), we took this covariate into account in the
randomization process. More precisely, we applied the stratified
randomization method to address the need of balancing the
groups for the amount of physical activity (20, 21). Following
this method, participants were stratified into two blocks (Highs
and Lows) of 19 participants each depending on the amount
of physical activity. More precisely, according to the mean
value of physical activity per week of the whole sample (2.87
± 0.99 h), the block of Highs was made of participants with
more than 2.87 h per week and the block of Lows was made
of participants with <2.87 h per week). Then, participants were
allocated to the experimental or control group by means of
simple randomization through a computer generated list that
guarantees the same number of subjects and equivalent physical
activity by type of intervention. In this way, sample size and
amount of physical activity were balanced in the experimental
and control group. After randomization, we confirmed that the
level of physical activity was balanced between the two groups
[t(34) = 1.031, p = 0.310]. Two experimenters (MA and ES)
enrolled participants, generated the random allocation sequence,
and assigned participants to interventions. The experimenters
and the participants were blinded for group allocation.
The study was conducted according to the principles
expressed in the Declaration of Helsinki and was approved by
the Ethical committee of Verona Hospital (Azienda Ospedaliera
Universitaria Intregrata, AOUI Verona, 766CESC). Written
informed consent was obtained before the start of the study.
The protocol is registered in ClinicalTrials.gov with the number
ID: NCT03539263. The full trial protocol can be accessed upon
request at Probiotical S.p.A. and to the principal investigator MF.
Procedure
The probiotic product or placebo was administered for 6 weeks
followed by a 3-week washout period for a total duration of
9 weeks. The experimental group received 42 sachets of the
product (one for each day), each containing 4 × 109 colony
forming unit/active fluorescent unit (CFU/AFU) 2.5 g freeze-
dried powder of the probiotic mixture containing Lactobacillus
fermentum LF16 (DSM 26956), L. rhamnosus LR06 (DSM 21981),
L. plantarum LP01 (LMG P-21021), and Bifidobacterium longum
BL04 (DSM 23233) (Probiotical S.p.A., Novara, Italy).
The mixture was composed with commercially
available probiotic strains extensively used for food
supplement formulations.
The study materials were analyzed by Biolab Research S.r.l.,
Novara, Italy, via flow cytometry (ISO 19344:2015 IDF 232:2015,
> 4 × 109 AFU) and plate count method (Biolab Research
Method 014-06, >4 × 109 CFU) to confirm target cell count.
The control group received 42 sachets of placebo, each containing
2.5 g of maltodextrin in powder form. The placebo powder was
indistinguishable from the probiotics powder in color, taste, and
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smell, but contained no probiotic bacteria. Participants were
instructed to dissolve the powder in water or milk and drink it
in the morning with breakfast.
A mobile application developed ad hoc (AgendaQR, Bussola
Labs, Verona, Italy) was installed on the participants’ phones at
the beginning of the study; adherence to the study protocol was
facilitated by means of a daily reminder to take the probiotics
product or placebo and to scan the QR code attached to the
sachet. If a participant failed to scan the code, the application kept
a record of the missed daily intake.
All participants completed an extensive battery of
psychological questionnaires (see next paragraph for a details)
at four time points: before intake of the probiotics product or
placebo (baseline) (T0), at 3 (T1), and 6 (T2) weeks after the
first intake, and then at 3 weeks of washout (T3). E-Prime 2.0
software (Psychology Software Tools Inc., Sharpsburg, PA, USA)
was used to present the questionnaires and record the responses.
Each session lasted about 45 min.
Questionnaires Measuring Mood-Related
Aspects
Leiden Index of Depression Sensitivity-Revised Test
The primary outcome of our study was the difference in the
scores at the Leiden Index of Depression Sensitivity-Revised
test (LEIDS-R) (22) between the experimental and control
groups. The LEIDS-R is a self-report questionnaire that tests
cognitive reactivity to sad mood, which is an index of cognitive
vulnerability to depression. It consists of 34 items describing
different situations. Before answering the items, participants
are asked to take a few minutes to imagine their feelings
and thoughts when they experience a sad mood. They then
rate how much each item applies to themselves on a 5-point
scale ranging from 0 (not at all) to 4 (very strongly). Of
note, the experimenter emphasizes that each item describes
a situation happening on a day that is not good, but you
don’t feel depressed. The LEIDS-R consists of 6 subscales:
Hopelessness/Suicidality (5 items), Acceptance/Coping (6 items),
Aggression (5 items), Control/Perfectionism (6 items), Risk
aversion (6 items), and Rumination (6 items). The total score
for each subscale is obtained by adding the scores from the
corresponding item. The range of the total score for the
Aggression and Hopelessness/Suicidality subscales is from 0 to
20. The range of the total score for the other three scales is
from 0 to 24. The higher the total subscale score, the higher the
vulnerability to the assessed dimension.
State Trait Anxiety Inventory
The State Trait Anxiety Inventory, STAI, (23) is a self-report
questionnaire that measures the presence and severity of current
symptoms of anxiety and the propensity to be anxious (24).
There are separate subscales for two anxiety components: state
anxiety (STAI—form Y1) and trait anxiety (STAI—form Y2).
Each subscale contains 20 items. The STAI—Y1 measures the
current anxiety state by asking participants to rate how they
actually feel (e.g., calm, tense, worried) on an intensity scale from
1 (not at all) to 4 (very much so). The STAI—Y2 measures the
propensity to anxiety by asking participants to rate how they
generally feel in their life (e.g., confident) on a frequency scale
from 1 (almost never) to 4 (almost always). The total score for
each subscale is obtained by adding the scores of all items. The
score for the anxiety-absent items are reversed. The range of the
total score for each subscale is 20–80, wherein the higher the
score, the higher the degree of state or trait anxiety. Scores of 39–
40 have been defined as a cut-off for clinically relevant symptoms
of state anxiety (24).
Beck Depression Inventory
The Beck Depression Inventory, BDI-2 (25), is a self-report
questionnaire that measures the occurrence and severity of
current depressive symptoms. It consists of 21 groups of
sentences describing different depression-related feelings and
thoughts (e.g., self-dislike, loss of interest, irritability, changes
in sleep pattern). Participants are asked to choose the statement
from a group of sentences that best describes how they have
been feeling in the past 2 weeks including the current day. Each
statement corresponds to a specific severity score (range, 0–3).
The total score is obtained by adding the statement scores (range,
0–63), wherein the higher the total score, the higher the severity
of depressive state (minimal depression, 0–13; mild depression,
14–19; moderate depression, 20–28; severe depression, 29–63).
Profile of Mood State
The Profile of Mood State, POMS, (26) is a self-report
questionnaire that assesses mood. It consists of 58 items (words
or sentences) that describe feelings that people usually have. For
each item, participants rate on a 5-point scale from 0 (not at all) to
4 (extremely) how they have been feeling the past week including
the current day. The items are grouped in 6 subscales: Tension
(9 items), Depression (15 items), Anger (12 items), Fatigue (7
items), Confusion (7 items), and Vigor (8 items). The Vigor
scale is in inverted relationship with the other scales since it
assesses positive feelings (e.g., to be lively, active, energetic). The
total score for each scale is obtained by adding the related item,
wherein the higher the total score of the scale, the higher the level
of the related mood.
Sleep Quality Questionnaire
Pittsburgh Sleep Quality Index
The Pittsburgh Sleep Quality Index, PSQI, (27, 28) is a self-
report questionnaire that assesses sleep quality for the majority
of days and nights in the past months. It consists of 19 questions.
The first four investigate usual bedtime, the number of minutes
needed to fall asleep, the usual getting up time, and the hours
of sleep per night. The other questions are related to other
aspects of sleep quality rated on scales appropriate for the
specific question. The items are weighted on a 0–3 interval scale
and grouped in seven component scores (i.e., subjective sleep
quality, sleep latency, sleep duration, use of sleeping medication,
daytime dysfunction, sleep duration, habitual sleep efficiency). A
global PSQI score (range, 0–21) is obtained by adding up the
component scores, wherein the lower the PSQI global score, the
better the sleep quality.
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Questionnaires Measuring
Personality-Related Aspects
Temperament and Character Inventory
The Temperament and Character Inventory, TCI, (29) is a self-
report, true-false questionnaire that measures two components
of personality: temperament and character. Temperament refers
to automatic responses to perceptual stimuli likely reflecting
hereditable biases in information processing (29). It consists
of four dimensions: novelty seeking (system of behavioral
activation), harm avoidance (system of behavioral inhibition),
reward dependence (system for maintenance of ongoing
behavior), and persistence (system of partial reinforcement and
active behavior despite fatigue and frustration). Based on the
psychobiological model of personality (29), each dimension
is related to specific neurotransmitters: dopamine for novelty
seeking; GABA and serotonin for harm avoidance; noradrenaline
and serotonin for reward dependence, and glutamate and
serotonin for persistence. Character refers to dimensions
determined by the environment rather than by inheritance.
These dimensions regulate the cognitive processes of perception
and emotion defined by the person’s temperament (30). The
character dimensions are: self-directedness (identification with
autonomous self and ability to solve situations); cooperativeness
(extent to which other people are viewed as part of the self);
and self-transcendence (identification with a unity of all things).
Based on this model of personality, the TCI consists of 240
items grouped on four temperament scales (40 items for novelty
seeking; 35 for harm avoidance; 24 for reward dependence; 8
for persistence) and three character scales (44 items for self-
directedness; 42 for cooperativeness; 33 for self-transcendence).
The total score for each scale is obtained by adding the
related items (range of total scores: novelty seeking, 0–40; harm
avoidance, 0–35; reward dependence, 0–24; persistence, 0–8; self-
directedness, 0–44; cooperativeness, 0–42; self-transcendence 0–
33). The higher the total score, the higher the level of the
personality dimension described by the scale.
Cope Orientation to the Problems Experienced—New
Italian Version
The Cope Orientation to Problem Experienced—New Italian
Version, COPE-NIV, (31) is a self-report questionnaire that
measures coping strategies: the cognitive and behavioral
strategies people use to manage stressful situations (32). The
COPE-NIV consists of 60 items that describe different coping
strategies. Participants are asked to rate each item on a frequency
scale from 1 (I usually don’t do this) to 4 (I usually do this). The
items are grouped in five essentially independent components:
social support (12 items), avoidance strategies (16 items), positive
attitude (12 items), problem solving (12 items), and turning to
religion (8 items). The total score for the subscales is obtained
by adding the corresponding item scores. The higher the total
subscale score, the higher the frequency in adopting the coping
strategy described by that subscale.
Behavioral Inhibition System and Behavioral
Activation System Scale
The Behavioral Inhibition and Behavioral Activation Scale,
BIS/BAS, (33) is a self-report questionnaire that measures an
individual’s sensitivity to behavioral inhibition and behavioral
activation systems. The behavioral inhibition system (BIS)
mediates responses to potential punishment and suppresses
behavior that is expected to lead to threat, punishment or non-
reward (34). Conversely, the behavioral activation or approach
system mediates responses to rewards expectancy (34) and
facilitates behavior that brings the person closer to expected
rewards. The BIS/BAS scale consists of 24 items grouped in four
subscales: BIS (7 items), BAS Drive (4 items), BAS Fun seeking
(4 items), and BAS Reward responsiveness (5 items). Four items
serve as control. Participants rate how much each statement
describes themselves from 0 (It does not describe me at all) to 5 (It
completely describes me). The total score for each scale is obtained
by adding the items of the respective scale; the total BIS score
ranges from 1 to 35 and the total BAS score ranges from 1 to 65.
The higher the total score, the higher the sensitivity of behavioral
inhibition and behavioral activation systems.
Life-Orientation Test-Revisited
The Life Orientation Test-revisited, LOT-R, (35) is a self-report
measure of dispositional optimism and pessimism. It consists of
10 items: 3 are worded positively; 3 are worded negatively; and
4 are control items. Participants rate their agreement with each
item on a 5-point scale from 0 (strongly disagree) to 4 (strongly
agree). The LOT-R total score is obtained by adding all items
except the 4 control items. The three negatively worded items
are related to pessimism and are reverse scored. The LOT-R
total score ranges from 0 to 24. The higher the total score, the
higher the degree of optimism (high optimism, 19–24; moderate
optimism, 14–18; low optimism, 0–13).
Data Analyses
Distribution of age and gender was analyzed with an independent
sample t-test and a chi-square test, respectively. Questionnaire
data were first checked for normality by means of the Shapiro–
Wilk test (p> 0.05). Since the data were not normally distributed,
non-parametric tests were used. The Friedman test was used
to compare questionnaire scores across time points (T0, T1,
T2, T3) separately for each group (experimental and control).
Post-hoc comparisons were performed using the Wilcoxon
signed-rank test. Bonferroni correction was applied and the
adjusted critical level of significance for multiple comparisons
was set at p < 0.017. The Mann–Whitney U-test was used to
compare questionnaire scores between-groups. P < 0.05 were
considered statistically significant. Spearman correlations were
used to explore the relationship between mood and sleep quality,
separately for each group. Mean and standard deviation of
questionnaire data are reported in Tables S1, S2.
RESULTS
Nineteen participants assumed probiotics and made up the
experimental group (7 women, mean age ± SD, 21.47 ± 2.22
years); 19 participants received placebo and made up the control
group (6 women,mean age, 22.53± 3.64 years). One subject from
the experimental group and four subjects from the control group
did not complete the study because they underwent therapeutic
interventions with antibiotics. The final study sample was 33
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subjects: 18 in the experimental group (7 women, mean age, 21.61
± 2.2 years) and 15 in the control group (5 women, mean age,
21.67 ± 2.19 years). The two groups did not differ by age [t(31)
= −0.115, p = 0.909] or gender distribution [χ2
(1)
= 0.109, p
= 0.741].
Recruitment started 28 November 2016 and follow-up
finished 15 June 2017.
Mood-Related Aspects
Leiden Index of Depression Sensitivity-Revised Test
No significant time effect on the total score and subscale scores
of the LEIDS-R was noted for the experimental and the control
group. There was a significant between-group difference in the
acceptance subscale scores at 6 weeks (T2). This difference was
due to the higher scores recorded in the experimental group
(mean ± SD, 5.33 ± 5.11) as compared to the control group
(mean ± SD, 2.93 ± 3.51) (Z = −2.162, p = 0.031, effect size
=−0.376) (Figure 1).
State Trait Anxiety Inventory
No significant time effect on STAI scores in the experimental
and the control group was found: STAI-Y1 (state anxiety)
(experimental group, p = 0.612; control group, p = 0.412) and
STAI-Y2 (trait anxiety) (experimental group, p = 0.161; control
group, p = 0.085). Moreover, there were no between-group
differences in STAI-Y1 (all time points, p > 0.218) and STAI-
Y2 (all time points, p > 0.436). The state and trait dimensions
of anxiety remained constant in both groups at all four time
points, discarding a potential effect of probiotics intake on both
anxiety components.
Beck Depression Inventory
No significant time effect on BDI-2 scores in the experimental
(p = 0.137) and the control group (p = 0.409) was found; there
were no between-group differences at any of the four time points
(all time points, p > 0.383). Probiotics intake had no effect on
depressive symptoms as assessed by the BDI-2.
Profile of Mood State
A significant time effect on the depression subscale scores for
the experimental group [χ2(3) =12.43, p = 0.006] was found.
Post-hoc comparisons with Wilcoxon signed rank test (after
Bonferroni correction, p< 0.017) showed that this result was due
to lower scores after 6 weeks of treatment (T2) (mean± SD, 6.22
± 7.26) compared to baseline (T0) (mean ± SD, 11.00 ± 9.45)
(Z = −2.596, p = 0.009, effect size = −0.433). Moreover, the
effect was maintained after 3 weeks of washout, as revealed by a
significant difference between T3 (mean ± SD, 5.67 ± 7.15) and
T0 (Z = −2.452, p = 0.014, effect size = −0.409). These results
suggest that the experimental group experienced a reduction in
depressive mood state and that this effect remained nearly stable
after 3 weeks of washout (Figure 2A).
A significant time effect [χ2(3) = 17.52, p = 0.001] was also
found on the anger-hostility scale scores for the experimental
group. Post-hoc comparisons showed that this effect was due to
lower scores after 3 weeks of probiotics intake (T1) (mean ± SD,
6.56 ± 4.87) compared to baseline (T0) (mean ± SD, 10.39 ±
6.79) (Z = −2.695, p = 0.007, effect size = −0.449), and after
6 weeks of probiotics intake (T2) (mean ± SD, 6.78 ± 5.11)
compared to baseline (Z = −2.411, p = 0.016, effect size =
−0.402), as well as after 3 weeks of washout (T3) (mean ± SD,
5.28± 4.66) compared to baseline (Z =−2.921, p= 0.003, effect
size=−0.487) (Figure 2B).
A significant time effect was noted for the fatigue subscale
scores [χ2(3) =11.75, p = 0.008]. This effect was due to a lower
score at T2 (mean ± SD, 7.06 ± 4.24) compared to T0 (mean
± SD, 8.89± 4.30) (Z =−2.802, p= 0.005, effect size=−0.467)
and at T3 (mean± SD, 5.33± 4.12) compared to T0 (Z=−2.556,
p = 0.011, effect size = −0.426) (Figure 2C). A significant time
effect was also observed for the subscale confusion [χ2(3) = 14.45,
p = 0.003]. This effect was not further confirmed at post-hoc
analysis, however (p > 0.022 for all comparisons). No significant
time effect on any of the subscales for the control group. Finally,
no between-group differences were found (p > 0.079 all-time
points and subscales).
Sleep Quality
Pittsburgh Sleep Quality Index
A significant time effect in the experimental group [χ2(3)= 12.16,
p = 0.007] was found. Post-hoc comparisons showed that this
effect was due to lower scores after 6 weeks of probiotics intake
(T2) (mean± SD, 4.00± 1.64) compared to baseline (T0) (mean
± SD, 5.61± 2.17) (Z =−2.820, p= 0.005, effect size=−0.470)
(Figure 3). No significant time effect was noted for the control
group nor were between-group differences found.
Correlations Between Mood and Sleep
Quality
In the experimental group significant positive correlations were
found between PSQI scores and STAI Y2 (T0, r = 0.716, p =
0.001; T1, r = 0.623 p = 0.006) and BDI2 (T2, r = 0.634, p
= 0.005). PSQI positively correlated also with several scales of
LEIDS-r: Hopelessness (T3, r = 0.502, p = 0.034); Acceptance
(T3, r = 0.834, p< 0.001); Aggression (T0, r = 0.544, p= 0.020);
Risk aversion (T0, r = 0.472, p = 0.048). Significant correlations
were also found with different scales of POMS as well. Precisely,
PSQI positively correlated with Tension (T0, r= 0.628, p= 0.005;
T2, r = 0.643, p = 0.004), Depression (T0, r = 0.709, p = 0.001;
T2, r = 0.549, p = 0.018), Anger (T0, r = 0.829, p < 0.001;
T2, r = 0.679, p = 0.002), Fatigue (T0, r = 0.595, p = 0.009;
T2, r = 0.560, p = 0.016), and Confusion (T0, r = 0.595, p =
0.009) subscales. Negative correlations, instead, were found with
the Vigor subscale (T0, r = −0.545, p = 0.019; T3, r = −0.507,
p = 0.032). As stated before, the higher the scores at PSQI, the
lower the sleep quality. Thus, positive correlations with measures
of anxiety (i.e., STAI Y2) and depression (i.e., BDI2) suggest that
the lower the sleep quality, the higher the anxiety and depression.
Similarly, poor sleep quality is related to higher hopelessness,
acceptance, aggression, risk aversion as measured by the LEIDS-
r subscales, and tension, depressive mood state, anger, fatigue,
and confusions as measured by the POMS subscales. Conversely,
the negative correlation with the Vigor subscale suggests that the
better the sleep quality, the higher the level of vigor experimented
by participants. In the control group PSQI positively correlated
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FIGURE 1 | Median LEIDS—R score, Acceptance subscale for the experimental (black columns) and the control (gray columns) groups at all-time points. Error bars
represent 95% Confidence Interval. Asterisks indicate between-groups significant differences (p < 0.05).
with STAI-Y1 (T1, r= 0.550, p= 0.034; T2, r= 0.638, p= 0.010),
STAI-Y2 (T1, r = 0.707, p= 0.003; T2, r = 0.738, p= 0.002) and
BDI2 (T1, r= 0.710, p= 0.003). Significant correlations were also
observed for several subscales of POMS. More precisely, sleep
quality positively correlated with Tension (T0, r = 0.537, p =
0.039; T1, r = 0.601, p = 0.018; T2, r = 0.595, p = 0.019), Anger
(T1, r= 0.615, p= 0.015), Fatigue (T2, r= 0.677, p= 0.006), and
Confusion (T1, r = 0.694, p = 0.004) subscales, while negatively
correlated with the Vigor subscale (T1, r = −0.771, p = 0.001;
T2, r = −0.537, p = 0.039). These results suggest that a poor
sleep quality relates to higher anxiety, depression, tension, anger,
fatigue, and confusion. Conversely, a good sleep quality relates to
higher vigor.
Personality-Related Aspects
Temperament and Character Inventory
No significant time effect on any of the TCI subscale scores
in either the experimental or the control group was found.
Significant between-group differences were found for four
subscale scores at different time points. There was a significant
group effect for the novelty seeking subscale score only at T3 (Z
= −2.209, p = 0.027, effect size = −0.385), where the scores
were higher for the experimental group. This finding might
suggest that at the last assessment the participants who had
taken probiotics for 6 weeks were more prone to look for new
experiences; in other words, they may have been more activated
by novel stimuli as compared to the controls. In addition,
the persistence subscale scores differed between the groups; the
difference was due to lower scores for the experimental group at
all-time points (T0, Z = −3.127, p = 0.002, effect size = −0.544;
T1, Z =−2.906, p= 0.004, effect size=−0.506; T2, Z =−2.948,
p = 0.003, effect size = −0.513; T3, Z = −2.820, p = 0.005,
effect size=−0.491). This means that starting from baseline, the
experimental group was less persistent and that these differences
remained constant independent of probiotics intake.
A significant group effect was found for the self-directedness
subscale scores at T3 (Z = −2.497, p = 0.013, effect size =
−0.435). This difference was due to the lower scores for the
experimental group, suggesting that at 3 weeks since their last
intake of the probiotic the experimental group was less self-
directed than the controls.
Finally, there was a significant between-group difference
in cooperativeness subscales scores at T2 (Z = −2.233, p =
0.026, effect size = −0.389), with lower scores noted for the
experimental group. This finding might suggest that after 6
weeks of probiotics intake, the participants who had taken the
probiotics were more self-focused than those who did not.
Coping Orientation to Problem Experienced
No significant time effect on any of the COPE subscale
scores in either the experimental or the control group was
noted. Significant between-group differences were found for the
Avoidance Strategies subscale scores at T2 (Z=−2.590, p= 0.010,
effect size = −0.451) and T3 (Z = −2.728, p = 0.006, effect size
= −0.475), where the scores were higher for the experimental
group, suggesting that they were more apt than the control group
to use avoidance strategies after 6 weeks of probiotics intake and
after 3 weeks of washout.
Moreover, there was a significant between-group difference in
the Positive Attitude subscale scores at T1 (Z = 2.412, p = 0.016,
effect size = −0.420) due to lower scores for the experimental
group, suggesting that after 3 weeks of probiotics intake, the
experimental group had a lower positive attitude toward problem
solving than the controls. This difference was not observed at the
other time points, however.
Behavioral Inhibition System and Behavioral
Activation System Scale
No differences between time points for either group nor
between-group differences were found. These results suggest
that probiotics intake did not affect the inhibition or the
activation system.
Life Orientation Test-Revisited Test (LOT-R)
No significant time effect on either group was found. Moreover,
no differences between-groups were found. These results suggest
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FIGURE 2 | Median POMS subscale score for the experimental (black columns) and the control (gray columns) groups at all-time points. (A) Depression subscale; (B)
Anger subscale; (C) Fatigue subscale. Error bars represent 95% confidence interval. Asterisks indicate within-groups significant differences (Bonferroni corrected
p < 0.017).
that probiotics intake did not influence the level of optimism in
the experimental group.
DISCUSSION
With this exploratory study we investigated the effect of
probiotics intake on different aspects of mood and dimensions
of personality in healthy individuals. Overall, probiotics intake
was noted to exert a positive effect on depressive mood state and
sleep quality. This effect was specific for the experimental group,
thus ruling out confounding factors like learning, expectations or
maturation.We suggest, with caution, that these findings provide
new support to the notion that probiotics may exert a beneficial
psychological influence.
Effect of Probiotics on Mood-Related
Aspects
Previous studies in non-clinical samples have demonstrated that
multispecies probiotics have positive effects on mood (12, 36,
37). These studies focused mainly on depression and anxiety,
whereas we extend previous findings with a more comprehensive
assessment of these functions during and after 6 weeks of
probiotics intake.
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FIGURE 3 | Median PSQI score for the experimental (black columns) and the control (gray columns) groups at all time points. Error bars represent 95% confidence
interval. Asterisks indicate within-groups significant differences (Bonferroni corrected p < 0.017).
Among the different indexes of cognitive reactivity to sad
mood assessed by means of the LEIDS-R, the scores for
acceptance were found to be higher in the experimental group
than the control group after 6 weeks of probiotics intake.
Acceptance is an emotion regulation strategy that facilitates
recovery from depression in clinical populations (38). We
speculate that increasing acceptance might protect healthy
individuals from developing depressive mood.
Like Steenbergen et al. (12), we found no significant
differences between-groups or across time points for depression
scores as assessed by the BDI. This was not surprising since our
participants all demonstrated being below the clinically relevant
score for depression, suggesting that they did not have depressive
symptoms. Nonetheless, using the POMS we were able to detect
specific changes in positive and negative mood in healthy
individuals. In line with previous studies (12, 36, 37), we found a
reduction in depressive mood state in the group that received the
probiotics. The depression subscale score was lower after 6 weeks
of probiotics intake, suggesting that the experimental group
benefited from probiotics intake. Interestingly, this positive effect
was maintained after 3 weeks of washout, suggesting a long-term
effect. Moreover, we found a reduction in anger as measured by
the anger subscale of the POMS. This reduction appeared at the
3-week assessment and was consistent across other time points.
Hence, the scores for anger were lower in the experimental
group not only during the 6-week period of probiotics intake
but also after 3 weeks of washout. The sense of fatigue was
also lower in the experimental group at 6 weeks of probiotics
intake and continued after the 3 weeks of washout. Since no
between-group differences were detected, caution is needed in
interpreting these findings. Nonetheless, we suggest that, overall,
these findings hint at a beneficial effect of probiotics intake in the
experimental group.
No significant differences were found for STAI scores, thus
suggesting no changes in state and trait anxiety as assessed by
STAI-Y1 and STAI-Y2. Of note, the STAY-Y1 measures the
perceived anxiety level at a precise time point. In our study,
this time point corresponded to the assessment sessions. The
lack of differences between-groups and across time points
may indicate that the study participants were relaxed and
did not feel they were under pressure while completing
the questionnaires, thus excluding potential biases due
to anxiety.
The STAI-Y2, instead, measures a more stable dimension
of anxiety, the trait anxiety, i.e., an individual’s propensity to
habitually give anxious responses. The lack of effect of probiotics
on this trait could be explained by the fact that healthy individuals
already have low anxiety scores that cannot be further lowered by
probiotics intake.
Effect of Probiotics on Sleep Quality
Although we did not find significant differences between the
experimental and control group at the PSQI, the former but
not the latter reported an improvement in sleep quality. More
precisely, the experimental group participants reported that
their sleep quality improved after 6 weeks of probiotics intake.
The conclusions that can be drawn from these findings are
limited by the lack of between-group differences. At any rate,
we suggest that probiotics intake had beneficial effects on sleep
quality in experimental group. Recent studies have demonstrated
that probiotics ameliorate sleep in patients with chronic fatigue
syndrome (39), chronic pain (40), and in stressed medical
students (41). Our finding extends previous observations,
suggesting that the probiotics mixture we used was effective in
improving sleep quality also in a healthy population. Moreover,
the improvement in sleep quality fits well with the reduction
in depressive mood state, anger, and fatigue we observed in
the experimental group. Previous studies demonstrated a strong
relationship between sleep quality and mood (15). This was
also the case of our study. Correlation analysis indeed, showed
that sleep quality correlated with different aspects of mood,
like anxiety, depressive symptoms, fatigue, anger, confusion and
vigor, and additionally, in the experimental group, with some
aspects of cognitive reactivity to sad mood (e.g., aggression, risk
aversion, acceptance and hopelessness). Probiotics might have
positively influenced mood not only by influencing emotional
processes, but also other related aspects such as sleep quality
as well.
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Effect of Probiotics on Aspects Related to
Personality and its Relationship With Mood
We found no differences in personality traits across time points,
suggesting that the two groups remained stable throughout the
study. This suggests that personality dimensions are complex and
consolidated features that cannot be easily modified over time.
Whether the lack of effect was due to the duration of the study
(too short) or to the dose of the probiotics (too small) will need
to be investigated in a future study.
At certain time points and for specific TCI subscales, however,
we found significant between-group differences. For instance,
novelty seeking scores (i.e., exhilaration in response to novel
stimuli) were higher for the experimental than the control group
at T3, i.e., after 3 weeks of washout. Caution is warranted when
interpreting these findings, however, since the between-group
difference in novelty seeking was not consistent across time
points. Nonetheless, we suggest that the improvement in mood
induced by the probiotics could have facilitated novelty seeking
in the experimental group. Support for this hypothesis derives
from the evidence that positive emotions trigger exploratory
behavior [for a review, see (42)]. Similarly, self-directedness
and cooperativeness subscale scores were significantly different
between the two groups only at T3 and at T2, respectively.
Once again, because these differences were present only at single
time points, it is difficult to draw strong associations with
probiotics intake.
Two subscales in the COPE inventory, the avoidance strategies
and the positive attitude subscales, revealed differences between
the two groups at more than one time point. We found
higher scores on the avoidance strategies subscale for the
experimental group compared to the control group at T2 (after
6 weeks of probiotics intake) and at T3 (after 3 weeks of
washout). This means that the experimental group participants
were more likely to adopt strategies based on avoidance (e.g.,
through denial of stressful situations) when they experienced
problems. Taking into account the findings on mood, we
speculate that because the experimental group participants felt
better, as shown by the reduced depressive mood state, anger
and fatigue, they were also more likely to avoid negative
thoughts or situations, which induced a positive bias in their
responses. In this regard, it has been demonstrated that people
who feel in a positive mood are motivated to maintain their
positive state (43). For instance, studies on risk-taking behavior
demonstrated that positive feelings can accentuate an aversion
toward risky options related to a higher probability of loss (43).
Of note, avoidance strategies allow to deny problems and related
emotions that alter positive mood. In this sense, they might
represent the “less risky option” to temporarily prevent loss of
a positive state. Following this line of reasoning, we believe
that the experimental group participants probably had a higher
propensity to adopt avoidance strategies in order to preserve
their acquired positive state. This is only speculative and cannot
be completely supported by our data; nonetheless, it deserves
further investigation.
Also, the positive attitude subscale scores were lower for
the experimental compared to the control group at T1 (at 3
weeks into the study). Positive attitude is an adaptive coping
strategy that allows individuals to positively reinterpret negative
situations (44). Hence, a lower score for this subscale suggests
that the experimental group participants were temporarily less
prone than the controls to positively reinterpret a negative
situation. How does this result fit with the amelioration of
mood observed in the experimental group? It has been widely
demonstrated that positive feelings can bias attention toward
mood-congruent stimuli (45, 46). In virtue of this congruency
effect, people who feel in a positive mood are apt to attend
to positive rather than negative events (46). We speculate
that, in virtue of a general positive mood, the experimental
group participants subjects did not need to reinterpret
negative situations probably because they tended to focus
on positive events congruent with their mood rather than on
negative events.
Limitations of the Study
Some limitations of this study should be acknowledged. For
instance, the small sample size and the potential pre-existing
group differences with regard to some personality traits (e.g.,
persistence subscale of the TCI) may limit generalizability of
the findings. Future studies with larger sample will allow
to apply a randomization method that allows to take into
account more than one covariate (21). Moreover, due to time
constraints, we used only dimensional questionnaires to assess
personality, thus limiting our findings. Future investigations
with categorical diagnostic tools (e.g., Structured Clinical
Interview for DSM-IV, SCID-II) will allow to achieve a more
comprehensive view by assessing personality disorders. Despite
these limitations, we think that our study indicates that
probiotics might help to promote psychological well-being. As
one of the possible underlying mechanisms, we speculate that
probiotics, by interacting with intestinal microbiota, facilitated
the production of precursors of neuroactive substances involved
in modulating emotional processing, sleep, and other brain
functions (5, 6). Since the current study did not focus on
changes in intestinal microbiota following probiotic intake,
this is only a speculation based on previous findings (5, 6).
Future studies on larger samples are needed to verify this
hypothesis and to uncover the biological mechanisms at the
basis of these effects by investigating the changes in the
intestinal microbiota related to probiotics intake. Moreover,
it would be interesting to extend these investigations to
clinical populations and verify whether the positive effects
of probiotics intake can be observed in such patients. If
so, this would suggest the use of probiotics as adjunctive
therapy for conditions characterized by altered mood and/or
sleep disturbances.
CONCLUDING REMARKS
We did not find significant differences between the experimental
and control group neither at mood-related questionnaires, nor
at the questionnaire assessing the quality of sleep. Nonetheless,
we found changes in mood state and sleep quality across
sessions in the experimental and not in the control group.
More precisely, our exploratory study shows an improvement
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across time in different aspects of the profile of mood state,
like sad mood, anger, and fatigue only in healthy individuals
which took probiotics. Sleep quality also reportedly improved
after probiotics intake. Of note, sleep quality strongly relates to
mood.More precisely, as suggested by the significant correlations
between sleep quality and mood-related questionnaires, the
higher the quality of sleep, the better the mood state in the
experimental and in the control group. Finally, significant
differences between-groups have been observed for some
personality-related questionnaires. In this regard, our findings
suggest that improving mood by means of probiotics intake
might additionally determine changes in cognitive strategies
to deal with problems by reducing sensitivity to negative
situations, as well as the need to deal with them. Moreover,
we speculate that ameliorating mood can differentially affect
an individual’s predisposition, for instance, by facilitating
novelty seeking.
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